TD Private Client Wealth’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $19.2K | Sell |
|
|||||
|
2025
Q2 | $22.9K | Buy |
|
|||||
|
2025
Q1 | $15.9K | Buy |
|
|||||
|
2024
Q4 | $10.8K | Hold |
|
|||||
|
2024
Q3 | $9.1K | Hold |
|
|||||
|
2024
Q2 | $10.9K | Hold |
|
|||||
|
2024
Q1 | $10.9K | Buy |
|
|||||
|
2023
Q4 | $8.04K | Hold |
|
|||||
|
2023
Q3 | $6.86K | Sell |
|
|||||
|
2023
Q2 | $5.94K | Hold |
|
|||||
|
2023
Q1 | $6.38K | Hold |
|
|||||
|
2022
Q4 | $7.53K | Hold |
|
|||||
|
2022
Q3 | $6.69K | Buy |
|
|||||
|
2022
Q2 | $5.95K | Sell |
|
|||||
|
2022
Q1 | $8.25K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $1.44K | Hold |
|
|||||
|
2021
Q2 | $1.46K | Hold |
|
|||||
|
2021
Q1 | $1.46K | Sell |
|
|||||
|
2020
Q4 | $5.08K | Hold |
|
|||||
|
2020
Q3 | $5.1K | Hold |
|
|||||
|
2020
Q2 | $6.47K | Sell |
|
|||||
|
2020
Q1 | $7.79K | Buy |
|
|||||
|
2019
Q4 | $6.02K | Buy |
|